Amedisys (AMED) Stock Statistics & Valuation Metrics

Amedisys has a market cap or net worth of $3.27B. The enterprise value is $3.43B.

Amedisys has 32,886,703 shares outstanding. The number of shares has decreased by -2.65% in one year.

Amedisys’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.48%.

The current PE Ratio of Amedisys is 38.7. Amedisys’s PEG ratio is ―.

In the last 12 months, Amedisys had revenue of 2.35B and earned 43.23M in profits. Earnings per share was 1.32.

In the last 12 months, operating cash flow was 239.43M and capital expenditures -4.41M, giving a free cash flow of 235.01M billion.

Amedisys pays an annual dividend of ―, resulting in a dividend yield of ―

Amedisys upcoming earnings date is Oct 29, 2025, After Close (Confirmed).

Amedisys as a current ratio of 1.23, with Debt / Equity ratio of 36.62%

In the past 12 months, Amedisys has paid 48.05M in taxes.

Amedisys EV to EBITDA ratio is 42.58, with an EV/FCF ratio of 14.54.

Amedisys has $337.30M in cash and marketable securities with $451.35M in debt, giving a net cash position of $114.05M billion.

Gross margin is 52.27%, with operating margin of 4.03%, and net profit margin of 1.84%.

The average price target for Amedisys is $101.00, which is 11.43% higher than the current price. The consensus rating is Hold